MENG, ZHAOYANG,REDDY, PANDURANGA ADULLA, P.,SIDDIQUI, M. ARSHAD,MANDAL, AMIT, K.,LIU, DUAN,ZHAO, LIANYUN,MCRINER, ANDREW
申请号:
EP11820437
公开号:
EP2608668A4
申请日:
2011.08.22
申请国别(地区):
EP
年份:
2014
代理人:
摘要:
This invention relates to novel fused tricyclic compounds under Formula I that are inhibitors of mammalian Target of Rapamycin (mTOR) kinase, which is also known as FRAP, RAFT, RAPT or SEP, and are useful in the treatment of cellular proliferative diseases, for example cancer and other proliferative disorders.